Literature DB >> 8027159

Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases.

A B Mullaji1, S S Upadhyay, E K Ho.   

Abstract

We have used dual-energy X-ray absorptiometry to measure bone mineral density (BMD) in patients with ankylosing spondylitis comparing 41 healthy control subjects and 33 patients with either mild or advanced ankylosing spondylitis. A Norland XR-28 bone densitometer was used to measure the BMD of the lumbar spine and that of the head, trunk, arms, femoral neck, Ward's triangle, legs, pelvis, and total body. Mild ankylosing spondylitis was defined as that showing no or incipient syndesmophytes between L1 and L5 vertebrae: we studied 16 men of mean age 37 years and six women of mean age 37 years. Advanced ankylosing spondylitis, in 11 men of mean age 42 years, showed a bamboo spine with bridging syndesmophytes across all disc spaces between L1 and L5. The mean BMD of the lumbar spine was significantly different in the patients and control subjects of the same sex (0.01 < p < 0.05, analysis of variance), being significantly reduced compared with control subjects in mild disease (0.001 < p < 0.01, t-test) and significantly increased in advanced disease over control subjects (0.01 < p < 0.05; t-test) and over patients with mild disease (0.001 < p < 0.01; t-test). The relevance of these findings to the aetiology and pathogenesis of spinal deformities and other complications in ankylosing spondylitis is discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8027159

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

1.  Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis.

Authors:  Mehmet Ali Ulu; Remzi Çevik; Banu Dilek
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

2.  Bone and stone in ankylosing spondylitis: osteoporosis and urolithiasis.

Authors:  Nurgül Arinci Incel; Figen Gökoğlu; Bariş Nacir; Nazmi Incel
Journal:  Clin Rheumatol       Date:  2005-12-07       Impact factor: 2.980

3.  Bone mass in axial spondyloarthritis: A literature review.

Authors:  Erkan Kilic; Salih Ozgocmen
Journal:  World J Orthop       Date:  2015-03-18

4.  Iatrogenic fractures in ankylosing spondylitis--a report of two cases.

Authors:  Michael Ruf; Sascha Rehm; Christiane Poeckler-Schoeniger; Harry R Merk; Juergen Harms
Journal:  Eur Spine J       Date:  2005-07-20       Impact factor: 3.134

5.  Osteopenia in men with mild and severe ankylosing spondylitis.

Authors:  H J Baek; S W Kang; Y J Lee; K C Shin; E B Lee; C D Yoo; Y W Song
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

6.  Study of bone mineral density in patients with ankylosing spondylitis.

Authors:  Hatinder Jeet Singh; Kaur Nimarpreet; Sibadatta Das; Ashok Kumar; Shesh Prakash
Journal:  J Clin Diagn Res       Date:  2013-12-15

7.  The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.

Authors:  Bedriye Mermerci Başkan; Yasemin Pekin Doğan; Filiz Sivas; Hatice Bodur; Kürşat Ozoran
Journal:  Rheumatol Int       Date:  2009-08-14       Impact factor: 2.631

Review 8.  High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.

Authors:  M A C van der Weijden; T A M Claushuis; T Nazari; W F Lems; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2012-06-16       Impact factor: 2.980

9.  Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies.

Authors:  M A C van der Weijden; J C van Denderen; W F Lems; M W Heymans; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2010-08-10       Impact factor: 2.980

Review 10.  Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited.

Authors:  Johannes L Bron; Mirjam K de Vries; Marieke N Snieders; Irene E van der Horst-Bruinsma; Barend J van Royen
Journal:  Clin Rheumatol       Date:  2009-03-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.